Polymorphisms at the ANRIL gene are linked to risk for many different cancers, as well as risk of atherosclerotic cardiovascular disease, bone mass, obesity and type 2 diabetes. Here, CDKN2B-AS1 is linked to type 2 diabetes mellitus.